
    
      In this study, a parallel controlled study will be conducted to recruit 60 patients with
      ADHD, 30 patients in the fNIRS group and 30 patients in the drug group. At the same time, 30
      healthy controls will be recruited. 6 weeks, 12 sessions of NIRS feedback will be given for
      participants in NIRS group and healthy controls. 6 weeks of first or second line medication
      will be given for participants of drug group. Magnetic resonance imaging will be performed at
      baseline for all participants. SNAP IV, PSQ, CGI will be evaluated at baseline, week 3, week
      6 and week 8 for ADHD participants.
    
  